Tavia Acquisition and Vita Inclinata Sign LOI for NASDAQ Listing
Vita Inclinata plans to go public on the NASDAQ via a de-SPAC transaction following a preliminary merger agreement with Tavia Acquisition Corp.
Read the full storyBleichroeder Acquisition Corp. III announced the pricing of its $300 million IPO, offering 30 million units at $10 each on the Nasdaq Global Market under the ticker BCCQU. Additionally, Mercator Acquisition Corp. raised $172.5 million through its own Nasdaq IPO. Meanwhile, Tavia Acquisition Corp. and Vita Inclinata Technologies signed a Letter of Intent for a business combination, which would result in Vita becoming a publicly traded company on Nasdaq through a de-SPAC process.
Vita Inclinata plans to go public on the NASDAQ via a de-SPAC transaction following a preliminary merger agreement with Tavia Acquisition Corp.
Read the full storyThe SPAC completed its initial public offering successfully, securing capital for future strategic acquisitions and mergers in growth sectors.
The SPAC priced 30 million units at $10 each, with trading expected to commence on the Nasdaq Global Market under the ticker BCCQU.